Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07696312

"Determination of Sensitivity and Specificity of Straight Leg Raise Test Via Transforaminal Nerve Root Block

This study aims to evaluate the diagnostic accuracy of the straight leg raise test in patients with suspected lumbosacral radicular pain. Lumbosacral radicular pain is often caused by lumbar disc herniation and may radiate from the lower back or buttock to the leg. Although the straight leg raise test is commonly used in clinical practice, its diagnostic performance has been reported to vary.

In this study, diagnostic transforaminal epidural steroid injection or selective nerve root block will be used as the reference standard. The sensitivity, specificity, likelihood ratios, and area under the curve of the straight leg raise test will be calculated. The findings may help guide clinicians in determining when the straight leg raise test is sufficient and when further diagnostic confirmation may be needed.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Marmara University Faculty of Medicine, Pendik Training and Research Hospital, Algology Department Recruiting

Istanbul, PENDİK, 34890, Turkey (Türkiye)

Location status: Recruiting

Location contact

SERDAR KOKAR

CONTACT

SRDRKKR@HOTMAİL.COM

+90 541 641 51 43

About this study

Low back pain is one of the leading causes of disability worldwide. Lumbosacral radicular pain is commonly caused by lumbar disc herniation and is characterized by pain radiating from the lower back or buttock to the leg in a dermatomal distribution. The straight leg raise test is a simple and widely used physical examination test for evaluating suspected lumbar radiculopathy; however, its diagnostic accuracy varies across studies.

This study aims to evaluate the diagnostic performance of the straight leg raise test in patients with suspected lumbosacral radicular pain. Diagnostic transforaminal epidural steroid injection or selective nerve root block will be used as the reference standard. Only technically selective injections performed without sedation and with a low volume of short-acting local anesthetic will be included in the analysis. The study will assess the sensitivity, specificity, likelihood ratios, and area under the curve of the straight leg raise test. The results may help clarify when the straight leg raise test is reliable on its own and when additional diagnostic confirmation may be needed for clinical decision-making.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age between 18 and 65 years.
  • Preliminary diagnosis of lumbar radicular pain based on medical history, physical examination, and lumbar magnetic resonance imaging.
  • Patients scheduled to undergo transforaminal epidural injection targeting the L4, L5, or S1 nerve root.

Exclusion criteria

  • Inability to access clinical or procedural records in the hospital system.
  • Absence of available radiological records related to the target level, if required.
  • Inability to provide reliable NRS or straight leg raise test assessment due to cognitive impairment or language barrier.
  • Coagulopathy, defined as INR > 1.5 or platelet count < 80,000/mm³, or inability to discontinue anticoagulant or antiplatelet therapy when required.
  • Local or systemic infection, or skin lesion at the planned injection site.
  • Pregnancy or breastfeeding.
  • Known severe hypersensitivity to iodinated contrast material or local anesthetics.
  • Progressive neurological deficit or cauda equina syndrome.
  • Bilateral or nearly bilateral pain with both sides being prominent and equivalent, or need for therapeutic injection at more than one level during the same session.
  • Epidural injection with local anesthetic and/or steroid at the same level within the last 6 weeks.
  • Active polyneuropathy or other diffuse neuropathies.
  • Active radicular pain originating from nerve roots other than L4, L5, or S1.
  • Requirement for mandatory sedation.

Treatment and study plan

Primary outcomes

  1. Diagnostic Performance of the Straight Leg Raise Test

    Time frame: Before and 1 hour after diagnostic transforaminal epidural steroid injection.

    The diagnostic performance of the straight leg raise test will be evaluated in patients with suspected lumbosacral radicular pain using diagnostic transforaminal epidural steroid injection as the reference standard.

Secondary outcomes

  1. Change in Pain Intensity Assessed by Visual Analog Scale

    Time frame: Before and 1 hour after diagnostic transforaminal epidural steroid injection.

    Pain intensity will be assessed using the Visual Analog Scale before and 1 hour after diagnostic transforaminal epidural steroid injection. The change in Visual Analog Scale score after the diagnostic intervention will be evaluated in patients with suspected lumbosacral radicular pain.

  2. DN-4 Quastionnaire

    Time frame: Before diagnostic transforaminal epidural steroid injection

    The DN-4 (Douleur Neuropathique en 4 Questions) is a brief and reliable screening questionnaire used to determine whether a patient's pain is of neuropathic origin. It consists of a total of 10 items. Its name, DN-4, derives from the fact that it includes 4 main sections. Seven of the questions relate to patient-reported sensory symptoms, while three are based on clinical examination findings. Each "yes" response scores 1 point, yielding a total score ranging from 0 to 10. A score above 4 indicates a high likelihood of neuropathic pain.

  3. Intervertebral Disc Degeneration Assessed by Pfirrmann Grading Scale

    Time frame: Using available lumbar magnetic resonance imaging obtained before or after the diagnostic intervention, up to November 1, 2026

    Intervertebral disc degeneration will be evaluated using the Pfirrmann grading scale on lumbar magnetic resonance imaging. Pfirrmann grades will be assessed in relation to clinical findings, straight leg raise test results, pain intensity, and response to the diagnostic intervention in patients with suspected lumbosacral radicular pain.

  4. Diagnostic Performance of the Bragard Test

    Time frame: Before and 1 hour after diagnostic transforaminal epidural steroid injection

    The diagnostic performance of the Bragard test will be evaluated in patients with suspected lumbosacral radicular pain. The Bragard test will be assessed before and 1 hour after diagnostic transforaminal epidural steroid injection, using the response to the diagnostic intervention as the reference standard.

  5. Nerve Root Compression Grade on Lumbar Magnetic Resonance Imaging

    Time frame: Using available lumbar magnetic resonance imaging during the study period, up to November 1, 2026

    The degree of nerve root compression will be evaluated on lumbar magnetic resonance imaging in patients with suspected lumbosacral radicular pain. Nerve root compression grade will be assessed in relation to straight leg raise test results, Bragard test results, pain intensity, and response to diagnostic transforaminal epidural steroid injection.

Study contacts

Contact information is provided by the study sponsor or research team.

MİKDAT CAN KARABİYİK

CONTACT

[email protected]

+90 537 91 92 156

SERDAR KOKAR

CONTACT

[email protected]

+90 541 641 51 43

Sponsors and collaborators

Lead sponsor

Marmara University

Other

Registry information

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Jul 10, 2026
Registry last updated
Jul 10, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.